Recent CUE News
- Form 8-K - Current report • Edgar (US Regulatory) • 10/08/2024 08:00:08 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 10/07/2024 09:07:34 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/04/2024 08:00:07 PM
- Cue Biopharma Announces Upcoming Scientific Presentations at the Society for Immunotherapy of Cancer’s (SITC) 39th Annual Meeting • GlobeNewswire Inc. • 10/04/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/27/2024 08:17:01 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 09/27/2024 08:05:39 PM
- Cue Biopharma Announces Pricing of $12.0 Million Public Offering • GlobeNewswire Inc. • 09/27/2024 03:26:30 AM
- Cue Biopharma Announces Proposed Public Offering • GlobeNewswire Inc. • 09/27/2024 03:10:15 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 09/26/2024 08:32:08 PM
- Cue Biopharma Announces Proposed Public Offering • GlobeNewswire Inc. • 09/26/2024 08:27:02 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 09/10/2024 08:00:02 PM
- Cue Biopharma Appoints Industry Veteran Lucinda Warren as Chief Business Officer • GlobeNewswire Inc. • 09/09/2024 12:00:00 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 09/05/2024 08:00:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/05/2024 08:00:02 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/03/2024 08:30:09 PM
- Cue Biopharma to Present at The Promise of Interleukin-2 Therapy Conference • GlobeNewswire Inc. • 09/03/2024 12:00:00 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 08/28/2024 08:00:05 PM
- Cue Biopharma Reports Second Quarter 2024 Financial Results and Recent Business Highlights • GlobeNewswire Inc. • 08/19/2024 08:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/16/2024 08:00:07 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2024 08:00:22 PM
- Cue Biopharma to Host Business Update Call and Webcast • GlobeNewswire Inc. • 08/13/2024 12:00:00 PM
- Cue Biopharma Announces Strategic Prioritization of Autoimmune Programs Enabling Optimization of Workforce and Reduction of Capital Requirements • GlobeNewswire Inc. • 07/25/2024 08:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/25/2024 08:00:08 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/07/2024 08:00:11 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/07/2024 08:00:11 PM
FEATURED Element79 Gold Corp. Reports Significant Progress in Community Relations and Development Efforts in Chachas, Peru • Oct 9, 2024 10:30 AM
Unitronix Corp Launches Share Buyback Initiative • UTRX • Oct 9, 2024 9:10 AM
BASANITE INDUSTRIES, LLC RECEIVES U.S. PATENT FOR ITS BASAFLEX™ BASALT FIBER COMPOSITE REBAR AND METHOD OF MANUFACTURING • BASA • Oct 9, 2024 7:30 AM
BNCM COMPLETES MERGER WITH DELEX HEALTHCARE • BNCM • Oct 8, 2024 9:54 AM
CBD Life Sciences, Inc. (CBDL) Reaches Unprecedented Heights With Explosive Growth and Strategic Expansion in 2024 • CBDL • Oct 8, 2024 8:00 AM
Unitronix Corp. to Invest $3 Million in USA Unity Coin Project • UTRX • Oct 7, 2024 7:08 AM